Medindia
Medindia LOGIN REGISTER
Advertisement

MarketsandMarkets: Obama's Healthcare Reform Bill and its Impact on the U.S. Healthcare Market (Pharmaceuticals, Medical Devices and Health Insurance)

Tuesday, August 10, 2010 Drug News
Advertisement
DALLAS, Texas, August 10, 2010 This report forecasts thefuture impacts of the Health Reform bill enacted by President Obama in March2010. The report focuses on the U.S. healthcare system and its majorstakeholders such as pharmaceutical manufacturers, medical devicesmanufacturers, and health insurance industry.
Advertisement

Browse in-depth TOC on Obama's Healthcare Reform Bill and its impact onthe U.S. Healthcare Market. Early buyers will receive 10% customization ofreportshttp://www.marketsandmarkets.com/Market-Reports/Impact-Obama-Health-US-240.html
Advertisement

(Due to the length of this URL, it may be necessary to copy and pastethis hyperlink into your Internet browser's URL address field. Remove thespace if one exists.)

The health reform bill set forth several provisions to improve thequality and efficiency of healthcare, address the inefficiencies of theexisting healthcare structure, and to decrease the number of uninsured peoplein the U.S. In order to implement a self-funded reform, the ObamaAdministration set forward provisions for cost containment and assessment ofannual fees (in the form of excise tax) on drug manufacturers, medical devicecompanies, and the private insurance industry over a period of 2010 to 2019.Successful implementation of the health reforms by 2019 would reduce federalbudgetary deficit by $143 billion from about $1.4 trillion in 2009.

The industry-specific provisions of the health reforms are expected tohave a mixed impact on drug manufacturers and medical device industry.Evaluating the health reforms from the perspective of changing equation amongindustry stakeholders, empowerment of consumers in the long run is likely tocreate a win-win situation for all stakeholders.

Scope and Format

The report forecasts and analyzes the future impact of the health reformson the U.S. healthcare industry. This covers direct as well as indirectimpacts of the provisions on pharmaceutical, medical devices, and healthinsurance industries. Indirect impact refers to provisions that do notspecifically apply to these industries. Each section offers a strategicanalysis of the impact of Obama's health reforms on the U.S. healthcarestructure.

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consultingcompany based in the U.S. We publish strategically analyzed market researchreports and serve as a business intelligence partner to Fortune 500 companiesacross the world. MarketsandMarkets also provides multi-client reports,company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials,automotive and transportation, banking and financial services, biotechnology,chemicals, consumer goods energy and power, food and beverages, industrialautomation, medical devices, pharmaceuticals, semiconductor and electronics,and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow byproviding apt business insight with our huge market intelligence repository.To know more about us and our reports, please visit our websitehttp://www.marketsandmarkets.comContact: Ms. Sunita 7557 Rambler Road Suite 727, Dallas, TX 75231 Tel: +1-888-989-8004 Email: [email protected] http://www.marketsandmarkets.com http://marketsandmarkets.wordpress.com/ http://marketsandmarkets.blogspot.com/

SOURCE MarketsandMarkets
Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close